Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Md Faruque Pathan"'
Autor:
Dina Shrestha, Sanjay Kalra, Noel Somasundaram, Guru Prasad Dhakal, Shahjada Selim, Mohammad Wali Naseri, A.H. Aamir, Santosh Shakya, Ali Latheef, Rucha Mehta, Md Faruque Pathan, Rakesh Sahay, Syed Abbas Raza, Nitin Kapoor
Publikováno v:
Clinical Epidemiology and Global Health, Vol 22, Iss , Pp 101315- (2023)
Background: The South Asian Region shoulders more than its fair share of health-related challenges. While we continue to tackle acute and communicable illness, newer challenges and concerns have emerged. These include the rapidly increasing metabolic
Externí odkaz:
https://doaj.org/article/29738b6639334a5198822665561e466c
Autor:
Mohammod Feroz Amin, Bishwajit Bhowmik, Rozana Rouf, Monami Islam Khan, Syeda Anika Tasnim, Faria Afsana, Rushda Sharmin, Kazi Nazmul Hossain, Md. Abdullah Saeed Khan, Samiha Mashiat Amin, Md Shek Sady Khan, Md Faruque Pathan, Mohammad Jahid Hasan
Publikováno v:
BMC Endocrine Disorders, Vol 22, Iss 1, Pp 1-14 (2022)
Abstract Background Diabetes mellitus (DM) is rising at a rapid rate worldwide. As a chronic, incurable metabolic disease, diabetes affects a person’s life in all ways. Studies thus far have focused on the impact of diabetes on the physical and men
Externí odkaz:
https://doaj.org/article/c65a06adf82a4554a3a3b3e290567387
Autor:
Bishwajit Bhowmik, Tasnima Siddiquee, Tareen Ahmed, Faria Afsana, M A Samad, Md Faruque Pathan, Nayla Cristina do Vale Moreira, Abdul Alim, Sarowar Uddin Milon, Mohammad Mahbubur Rahman, Rie Ozaki, Farook Azam Khan, AHM Enayet Hossain, Hajera Mahtab, Akhtar Hussain, A K Azad Khan
Publikováno v:
Journal of Diabetology, Vol 12, Iss 4, Pp 383-390 (2021)
Similar to many other countries around the world, Bangladesh is also suffering from a pandemic of diabetes. It makes the most significant contribution to morbidity and mortality in this country. Despite the high burden of diabetes, health care is sti
Externí odkaz:
https://doaj.org/article/9da2cf63934a4edaa3c317ac9737dabf
Autor:
A K Azad Khan, Jagannath Malo, Md Jahangir Alam, Salequl Islam, Md Abdul Mottalib, Md Mehedi Hasan Rocki, Ginok Barmon, Shamema Akter Tinni, Swapan K Barman, Tapas Sarker, Md Nayeemul Islam Khan, Kanakaraju Kaliannan, Muhammad Abul Hasanat, Salimur Rahman, Md Faruque Pathan, Madhu S Malo
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 10, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/006e706154d14e2283ed77f839b9ba03
Autor:
Noel Somasundaram, Manilka Sumanatilleke, S. Abbas Raza, Sarita Bajaj, Rakesh Sahay, S. V. Madhu, Md Faruque Pathan, Faria Afsana, Prasad Katulanda, Ali Jawa, Charles Antonypillai, Dina Shrestha, Abdul Wassy Sultani, Mohammad Wali Naseri, Ali Latheef, Ariane Brusselmans, Andre Lacroix, Sanjay Kalra
Publikováno v:
Sri Lanka Journal of Diabetes Endocrinology and Metabolism, Vol 9, Iss 2, Pp 87-92 (2019)
No abstract available
Externí odkaz:
https://doaj.org/article/8cef35bfab174c8aa3f295a77ab2c231
Pragmatic use of insulin degludec/insulin aspart co-formulation: A multinational consensus statement
Autor:
Sanjay Kalra, Zafar A Latif, Abdurrahman Comlekci, Guillermo Gonzalez Galvez, Rached Malik, Md Faruque Pathan, Ajay Kumar
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 20, Iss 4, Pp 542-545 (2016)
Insulin degludec/insulin aspart (IDegAsp) is a modern coformulation of ultra-long-acting basal insulin degludec, with rapid-acting insulin aspart. IDegAsp provides effective, safe, well-tolerated glycemic control, with a low risk of hypoglycemia whil
Externí odkaz:
https://doaj.org/article/ba9f14ce55af4b4eb0fab7062ec19338
Autor:
Sanjay Kalra, A H Aamir, Abbas Raza, A K Das, A K Azad Khan, Dina Shrestha, Md Faisal Qureshi, Md Fariduddin, Md Faruque Pathan, Fatema Jawad, Jyoti Bhattarai, Nikhil Tandon, Noel Somasundaram, Prasad Katulanda, Rakesh Sahay, Sanjib Dhungel, Sarita Bajaj, Subhankar Chowdhury, Sujoy Ghosh, S V Madhu, Tofail Ahmed, Uditha Bulughapitiya
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 19, Iss 5, Pp 577-596 (2015)
Since their introduction in clinical practice in the 1950′s, Sulfonylureas (SUs) have remained the main-stay of pharmacotherapy in the management of type 2 diabetes. Despite their well-established benefits, their place in therapy is inappropriately
Externí odkaz:
https://doaj.org/article/0dcb343ef2b143719638cced8f8a3ddc
Autor:
Shahana Shermin, Md Ehsanul Huq, Sabura Rahman, Fahmida Akter, Nazmul Kabir Qureshi, AHM Aktaruzzaman, Md Faruque Pathan, Md Ruhul Amin, Md Rezwanur Rahman
Publikováno v:
Delta Medical College Journal, Vol 1, Iss 1, Pp 3-7 (2013)
Backgound: The number of hypogonads is increasing day by day. It may be due to sedentary life style with increased obesity, increased tension or stressed lifestyle among all groups of populations. Visceral obesity is associated with insulin resistanc
Externí odkaz:
https://doaj.org/article/fdc12a9450cb4cccabea41c15c1ebad2
Autor:
Mir Iftikhar Bashir, Md Faruque Pathan, Syed Abbas Raza, Jamal Ahmad, A K Azad Khan, Osama Ishtiaq, Rakesh K Sahay, Aisha Sheikh, Abdul Hamid Zargar
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 16, Iss 4, Pp 503-507 (2012)
It is obligatory for all adult Muslims to observe fast during the holy month of Ramadan, but sick individuals including those with diabetes mellitus are exempted from the duty of fasting. Specific medical advice must be provided to individual patient
Externí odkaz:
https://doaj.org/article/4dbb5e0a7511412a8a3004becd7f2c40
Autor:
Md Faruque Pathan, Rakesh Kumar Sahay, Abdul Hamid Zargar, Syed Abbas Raza, A K Azad Khan, Mohammed Ashraf Ganie, Nazrul Islam Siddiqui, Firoz Amin, Osama Ishtiaq, Sanjay Kalra
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 16, Iss 4, Pp 499-502 (2012)
A person with diabetes mellitus (DM) has every right to perform the ritual of fasting during Ramadan. In daily practice we come across both type 1 and type 2 DM who wish to fast. This Consensus Statement describes the pre-Ramadan assessment, planning
Externí odkaz:
https://doaj.org/article/59a51d9104844bc2ac1d805284699cc7